Abstract
Mutagenesis has been the foundation of genetics in most model organisms, from prokaryotes to the fruit flies. The simplicity of mutagenizing and propagating these creatures is critical for projects designed to isolate mutations affecting most any imaginable biological process. Not only has mutagenesis been exploited for the identification of phenotypic mutants, but also for the derivation of chromosomal aberrations, such as deletions and inversions, that are powerful genetic tools for many sorts of experiments. The laboratory mouse, which serves as the most important and powerful animal model for human genetics and disease, is only recently being widely exploited by classical phenotype-driven mutagenesis. The limitation has been (and still remains) related to the biology and life cycle of the mouse, which renders large-scale mutagenesis projects rather cumbersome and expensive. Is classical chemical mutagenesis really worthwhile, given the powerful germline manipulation technologies available for mic e Are there new technologies that will render classical mutagenesis obsolete In this review, I shall discuss the tools of mutagenesis that are available for mice, and consider emerging and potential future technologies that will ultimately allow us to investigate, in an unprecedented way, the in vivo function of all mammalian genes.
Keywords: Mutagenesis, CDNA, EST Expressed Sequence Tag
Current Genomics
Title: Mutagenesis in Mice Modern Times
Volume: 1 Issue: 3
Author(s): John C. Schimenti
Affiliation:
Keywords: Mutagenesis, CDNA, EST Expressed Sequence Tag
Abstract: Mutagenesis has been the foundation of genetics in most model organisms, from prokaryotes to the fruit flies. The simplicity of mutagenizing and propagating these creatures is critical for projects designed to isolate mutations affecting most any imaginable biological process. Not only has mutagenesis been exploited for the identification of phenotypic mutants, but also for the derivation of chromosomal aberrations, such as deletions and inversions, that are powerful genetic tools for many sorts of experiments. The laboratory mouse, which serves as the most important and powerful animal model for human genetics and disease, is only recently being widely exploited by classical phenotype-driven mutagenesis. The limitation has been (and still remains) related to the biology and life cycle of the mouse, which renders large-scale mutagenesis projects rather cumbersome and expensive. Is classical chemical mutagenesis really worthwhile, given the powerful germline manipulation technologies available for mic e Are there new technologies that will render classical mutagenesis obsolete In this review, I shall discuss the tools of mutagenesis that are available for mice, and consider emerging and potential future technologies that will ultimately allow us to investigate, in an unprecedented way, the in vivo function of all mammalian genes.
Export Options
About this article
Cite this article as:
Schimenti C. John, Mutagenesis in Mice Modern Times, Current Genomics 2000; 1 (3) . https://dx.doi.org/10.2174/1389202003351409
DOI https://dx.doi.org/10.2174/1389202003351409 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
Call for Papers in Thematic Issues
Current Genomics in Cardiovascular Research
Cardiovascular diseases are the main cause of death in the world, in recent years we have had important advances in the interaction between cardiovascular disease and genomics. In this Research Topic, we intend for researchers to present their results with a focus on basic, translational and clinical investigations associated with ...read more
Deep learning in Single Cell Analysis
The field of biology is undergoing a revolution in our ability to study individual cells at the molecular level, and to integrate data from multiple sources and modalities. This has been made possible by advances in technologies for single-cell sequencing, multi-omics profiling, spatial transcriptomics, and high-throughput imaging, as well as ...read more
New insights on Pediatric Tumors and Associated Cancer Predisposition Syndromes
Because of the broad spectrum of children cancer susceptibility, the diagnosis of cancer risk syndromes in children is rarely used in direct cancer treatment. The field of pediatric cancer genetics and genomics will only continue to expand as a result of increasing use of genetic testing tools. It's possible that ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Fluorescence Imaging in Cancerology
Current Molecular Imaging (Discontinued) Bifrontal ECT: A Systematic Review and Meta-Analysis of Efficacy and Cognitive Impact
Current Psychiatry Reviews The Metabolism and Disposition of Koumine, Gelsemine and Humantenmine from Gelsemium
Current Drug Metabolism The Role of Focal Adhesion Kinase in Lung Cancer
Anti-Cancer Agents in Medicinal Chemistry Direct Modification of Bioactive Phenothiazines by Exposure to Laser Radiation
Recent Patents on Anti-Infective Drug Discovery Propranolol Safety Profile in Children
Current Drug Safety Flavonoids: Cellular and Molecular Mechanism of Action in Glucose Homeostasis
Mini-Reviews in Medicinal Chemistry Homocysteine, Cardiovascular Inflammation, and Myocardial Remodeling
Cardiovascular & Hematological Disorders-Drug Targets 6H-Indolo[2,3-b]Quinoxalines: DNA and Protein Interacting Scaffold for Pharmacological Activities
Mini-Reviews in Medicinal Chemistry Chronic Kidney Disease and the Search for New Biomarkers for Early Diagnosis
Current Medicinal Chemistry Polycystic Ovary Syndrome and Infertility: From Molecular Perspective
Current Women`s Health Reviews Pleiotropic Effects of Glucagon-like Peptide-1 (GLP-1)-Based Therapies on Vascular Complications in Diabetes
Current Pharmaceutical Design Molecular Modelling and QSAR of Reversible Acetylcholines-terase Inhibitors
Current Medicinal Chemistry Amyloid Forming Proteases: Therapeutic Targets for Alzheimers Disease
Current Pharmaceutical Design Commentary 1 (Research Highlights: Parkinson’s Disease and α-Synuclein: Passing it on)
CNS & Neurological Disorders - Drug Targets Regulation of Innate Immune Responses in the Central Nervous System
CNS & Neurological Disorders - Drug Targets Vitamins and Type 2 Diabetes Mellitus
Endocrine, Metabolic & Immune Disorders - Drug Targets Cancer and Virus Leads by HTS, Chemical Design and SEA Data Mining
Current Topics in Medicinal Chemistry Roles of Arterial Baroreceptor Reflex During Bezold-Jarisch Reflex
Current Cardiology Reviews Pharmacologic Treatment of Restless Legs Syndrome
Current Neuropharmacology